We take all instances of illegal behavior seriously. Anyone convicted of violating these laws should be punished appropriately, vigorous, ethical competition is the foundation of the generic drug and biosimilar industry. Competition allows our companies to drive enormous savings and pass them on to patients, taxpayers and health care payors.